VAXCYTE, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VAXCYTE, INC. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $41.79M.
- VAXCYTE, INC. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $12.12M.
- VAXCYTE, INC. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $264.08M.
- VAXCYTE, INC. stock issued during period, value, new issues for fiscal 2023 was $90.74M, a 88.05% decline from fiscal 2022.
- VAXCYTE, INC. stock issued during period, value, new issues for fiscal 2022 was $759.18M, a 5382.64% increase from fiscal 2021.
- VAXCYTE, INC. stock issued during period, value, new issues for fiscal 2021 was $13.85M, a 94.76% decline from fiscal 2020.
- VAXCYTE, INC. stock issued during period, value, new issues for fiscal 2020 was $264.01M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-12-31 | $90.74M 10-K · filed 2026-02-24 | |
| 2023-03-31 | $41.79M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $759.18M 10-K · filed 2023-02-27 | |
| 2021-12-31 | $13.85M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $12.12M 10-Q · filed 2021-11-10 | |
| 2020-12-31 | $264.01M 10-K · filed 2023-02-27 | |
| 2020-06-30 | $264.08M 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |